Maytus Capital Management LLC grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 25.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,000 shares of the semiconductor company’s stock after buying an additional 1,200 shares during the period. Maytus Capital Management LLC’s holdings in Synopsys were worth $2,818,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its stake in Synopsys by 7.7% in the fourth quarter. Russell Investments Group Ltd. now owns 234,461 shares of the semiconductor company’s stock worth $110,238,000 after purchasing an additional 16,663 shares during the period. Kemnay Advisory Services Inc. purchased a new stake in Synopsys in the fourth quarter worth $35,000. Captrust Financial Advisors grew its stake in Synopsys by 61.5% in the fourth quarter. Captrust Financial Advisors now owns 11,020 shares of the semiconductor company’s stock worth $5,176,000 after purchasing an additional 4,198 shares during the period. Fred Alger Management LLC purchased a new stake in Synopsys in the fourth quarter worth $3,548,000. Finally, &PARTNERS grew its stake in Synopsys by 5.5% in the fourth quarter. &PARTNERS now owns 13,329 shares of the semiconductor company’s stock worth $6,260,000 after purchasing an additional 696 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several brokerages recently weighed in on SNPS. Wells Fargo & Company upped their price target on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a research note on Wednesday, May 27th. HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target on the stock. in a research note on Friday, February 20th. Robert W. Baird set a $558.00 price target on Synopsys in a research note on Thursday, May 28th. Finally, BNP Paribas Exane upped their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Synopsys presently has a consensus rating of “Hold” and a consensus price target of $563.81.
Synopsys Trading Down 1.3%
NASDAQ SNPS opened at $448.38 on Wednesday. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The stock has a market cap of $85.86 billion, a P/E ratio of 103.79, a P/E/G ratio of 2.67 and a beta of 1.22. The stock’s fifty day moving average price is $475.78 and its 200-day moving average price is $461.46. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the prior year, the firm posted $3.67 earnings per share. The company’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced a collaboration with Murata Manufacturing to expand access to simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that could strengthen adoption of its design software and deepen customer usage. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A valuation note said SNPS looks “fairly valued” on a DCF basis around $394, suggesting the stock may not be deeply undervalued after its recent pullback. SNPS Fairly Valued by DCF at 394
- Neutral Sentiment: Brokerage coverage remains mixed, with the consensus rating still at “Hold” despite several higher price targets from analysts. Synopsys: Long-Term Opportunity Outweighs Near-Term Headwinds
- Negative Sentiment: Recent insider selling by top executives may be creating near-term pressure on the shares, even though the transactions were pre-planned and not necessarily a sign of weakening fundamentals. Top Synopsys Executive Makes Major Move With Insider Stock Sale
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
